These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16321730)

  • 21. Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring.
    De Hert M; van Eyck D; De Nayer A
    Int Clin Psychopharmacol; 2006 Mar; 21 Suppl 2():S11-5. PubMed ID: 16601508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
    Yang M; Barner JC; Lawson KA; Rascati KL; Wilson JP; Crismon ML; Worchel J; Mascarenas CA
    Ann Pharmacother; 2008 Sep; 42(9):1229-38. PubMed ID: 18682544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder.
    Gentile S
    J Clin Psychopharmacol; 2007 Feb; 27(1):35-45. PubMed ID: 17224710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnoses and antipsychotic treatment among youths in a public mental health system.
    Patel NC; Crismon ML; Shafer A
    Ann Pharmacother; 2006 Feb; 40(2):205-11. PubMed ID: 16434563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics.
    Coughlin M; Goldie CL; Tregunno D; Tranmer J; Kanellos-Sutton M; Khalid-Khan S
    Int J Ment Health Nurs; 2018 Jun; 27(3):1188-1198. PubMed ID: 29205757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
    Olfson M; Blanco C; Liu L; Moreno C; Laje G
    Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics.
    Stein K
    J Am Diet Assoc; 2010 Jul; 110(7):992-1001. PubMed ID: 20630154
    [No Abstract]   [Full Text] [Related]  

  • 28. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
    Coughlin M; Goldie CL; Tranmer J; Khalid-Khan S; Tregunno D
    Can J Psychiatry; 2018 Apr; 63(4):240-249. PubMed ID: 29528720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.
    Volavka J; Citrome L
    Expert Opin Pharmacother; 2009 Aug; 10(12):1917-28. PubMed ID: 19558339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.
    Kapetanovic S; Aaron L; Montepiedra G; Sirois PA; Oleske JM; Malee K; Pearson DA; Nichols SL; Garvie PA; Farley J; Nozyce ML; Mintz M; Williams PL;
    AIDS Patient Care STDS; 2009 Nov; 23(11):939-47. PubMed ID: 19827949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
    Deurell M; Weischer M; Pagsberg AK; Labianca J
    Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current strategies for predicting side effects from second generation antipsychotics in youth.
    Brown JT; Campo-Soria C; Bishop JR
    Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):655-664. PubMed ID: 33896324
    [No Abstract]   [Full Text] [Related]  

  • 33. Naturalistic impact of second-generation antipsychotics on weight gain.
    Brixner DI; Said Q; Corey-Lisle PK; Tuomari AV; L'italien GJ; Stockdale W; Oderda GM
    Ann Pharmacother; 2006 Apr; 40(4):626-32. PubMed ID: 16569802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective Study.
    Ilies D; Huet AS; Lacourse E; Roy G; Stip E; Amor LB
    Can J Psychiatry; 2017 Dec; 62(12):827-836. PubMed ID: 28673098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of antipsychotics in children and adolescents.
    Kapetanovic S; Simpson GM
    Expert Opin Pharmacother; 2006 Oct; 7(14):1871-85. PubMed ID: 17020414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE).
    Fischer-Barnicol D; Lanquillon S; Haen E; Zofel P; Koch HJ; Dose M; Klein HE;
    Neuropsychobiology; 2008; 57(1-2):80-7. PubMed ID: 18515977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reaction on 'Antipsychotics and metabolic abnormalities in children and adolescents a review of the literature and some recommendations'].
    Roke Y
    Tijdschr Psychiatr; 2010; 52(7):535-6; discussion 536. PubMed ID: 20623452
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
    Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
    J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperprolactinemia-related adverse events associated with antipsychotic treatment in children and adolescents.
    Jerrell JM; Bacon J; Burgis JT; Menon S
    J Adolesc Health; 2009 Jul; 45(1):70-6. PubMed ID: 19541252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.